Dingdang Health Technology Group Ltd. disclosed that it bought back 57,000 ordinary shares on the Hong Kong Stock Exchange on 22 September 2026. The shares were repurchased at prices ranging between HKD 0.78 and HKD 0.80, for an aggregate consideration of HKD 45,388.50. All repurchased shares will be held as treasury stock. No shares were cancelled.
Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined to 1.24 billion from 1.24 billion previously, representing a marginal 0.0046% reduction. Treasury shares increased to 4.83 million, while the company’s total issued share capital remained unchanged at 1.24 billion shares.
The buyback forms part of the repurchase mandate granted on 23 June 2026, which authorises Dingdang Health to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now total 7.69 million shares, equivalent to 0.62% of the company’s issued share base as at the mandate date. In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 22 October 2026, unless prior approval is obtained from the Exchange.
Comments